Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05526898 · ClinicalTrials.gov registry record · NA
Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis
A NA study of Knee Osteoarthritis, sponsored by Syntr Health Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 2
- Study locations
NCT05526898: Recruiting NA study of Knee Osteoarthritis, sponsored by Syntr Health Technologies.
NCT05526898 is a NA study of Knee Osteoarthritis that is actively recruiting participants, run by Syntr Health Technologies. The registered enrollment target is 176 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05526898, a NA study of Knee Osteoarthritis, is actively recruiting participants, sponsored by Syntr Health Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in Orthopedic Surgery, specifically Knee Osteoarthritis. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an injection of autologous microsized adipose tissue in the treatment sites or Standard of Care.
Primary Outcome
Change of WOMAC Score from Baseline
Conditions Studied
Interventions
- DEVICE SyntrFuge System
- DRUG Triamcinolone Injection
Study Locations (2)
California
- Irvine Site 1 - Irvine
- Irvine Site 2 - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT05526898 shows while recruiting
NCT05526898 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which SyntrFuge System is the first listed.
NCT05526898 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05526898 about?
NCT05526898 is a clinical study titled "Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis". This is an multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in Orthopedic Surgery, specifically Knee Osteoarthritis. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by ...
What is the current status of trial NCT05526898?
This trial is currently recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2024-10-01. Estimated completion is 2025-12.
What conditions does trial NCT05526898 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT05526898?
The interventions under investigation include: SyntrFuge System (DEVICE), Triamcinolone Injection (DRUG).
Who is sponsoring clinical trial NCT05526898?
This trial is sponsored by Syntr Health Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05526898 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05526898's enrollment target sits among peer trials
176 27th of 101 higher than 74 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
-
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
RECRUITING · NA
-
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
RECRUITING · NA
-
Investigating Patient Satisfaction With Smart Knee Implants
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
-
Knee Biofeedback Rehabilitation Through Game Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI